Antiretroviral agents - How best to protect infants from HIV and save their mothers from AIDS

被引:26
作者
Coovadia, H [1 ]
机构
[1] Univ Kwazulu Natal, Nelson Mandela Sch Med, Durban, South Africa
关键词
D O I
10.1056/NEJMe048128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:289 / 292
页数:4
相关论文
共 16 条
[1]  
[Anonymous], AIDS EP UPD
[2]  
[Anonymous], ANT DRUGS PREV MOTH
[3]  
CHALERMCHOKCHAR.A, 2004, 11 C RETR OPP INF SA, P96
[4]   Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: A substudy of Pediatric AIDS Clinical Trials Group protocol 316 [J].
Cunningham, CK ;
Chaix, ML ;
Rekacewicz, C ;
Britto, P ;
Rouzioux, C ;
Gelber, RD ;
Dorenbaum, A ;
Delfraissy, JF ;
Bazin, B ;
Mofenson, L ;
Sullivan, JL .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (02) :181-188
[5]  
DABIS F, 2003, 2 INT AIDS SOC C HIV
[6]   Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission - A randomized trial [J].
Dorenbaum, A ;
Cunningham, CK ;
Gelber, RD ;
Culnane, M ;
Mofenson, L ;
Britto, P ;
Rekacewicz, C ;
Newell, ML ;
Delfraissy, JF ;
Cunningham-Schrader, B ;
Mirochnick, M ;
Sullivan, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02) :189-198
[7]   Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012) [J].
Eshleman, SH ;
Guay, LA ;
Mwatha, A ;
Brown, ER ;
Cunningham, SP ;
Musoke, P ;
Mmiro, F ;
Jackson, JB .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (02) :126-130
[8]   Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) [J].
Eshleman, SH ;
Mracna, M ;
Guay, LA ;
Deseyve, M ;
Cunningham, S ;
Mirochnick, M ;
Musoke, P ;
Fleming, T ;
Fowler, MG ;
Mofenson, LM ;
Mmiro, F ;
Jackson, JB .
AIDS, 2001, 15 (15) :1951-1957
[9]   The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment - What so we really know? [J].
Fowler, MG ;
Mofenson, L ;
McConnell, M .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (03) :308-311
[10]  
GIAQUINTO C, 2003, INFECT DIS S, V106, P88